Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 105.59 | N/A |
| PEG Ratio (TTM) | 1.03 | N/A |
| P/S Ratio (TTM) | 2.38 | N/A |
| P/B Ratio (TTM) | -40.32 | N/A |
| P/FCF Ratio (TTM) | -18.72 | N/A |
| Price to 5YR AVG Earnings Ratio | 22.98 | N/A |
| Price to 5YR AVG FCF Ratio | 29.04 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.57% | N/A |
| ROE (TTM) | -27.81% | N/A |
| Net Profit Margin (TTM) | 2.25% | N/A |
| ROIC 5YR AVG | 23.25% | N/A |
Growth (78%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 345.86% | 85.74% | 31.04% |
| Revenue | 2.18% | 15.07% | 5.02% |
| Net Income | 350.45% | 74.32% | 24.77% |
| Cash Flow | -145.04% | 30.90% | 0.75% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.43 | N/A |
| Quick Ratio (TTM) | 0.33 | N/A |
| D/E Ratio (TTM) | -6.27 | N/A |
| Interest Coverage (TTM) | 1.36 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.82 | N/A |
| LTL to 5YR AVG FCF | 13.92 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.34% | N/A |